Article open access publication

Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H196

Stem Cell Research, Elsevier, ISSN 1873-5061

Volume 16, 1, 2016

DOI:10.1016/j.scr.2015.12.031, Dimensions: pub.1045987113, PMID: 27345804,



  1. (1) University of Copenhagen, grid.5254.6, KU
  2. (2) Neurogenetic Research Laboratory, Danish Dementia Research Centre, Department of Neurology, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, Denmark
  3. (3) Bioneer (Denmark), grid.424169.c
  4. (4) Mahidol University, grid.10223.32
  5. (5) University of Tübingen, grid.10392.39









Spinocerebellar ataxia type 2 (SCA2) is a neurodegenerative disease primarily affecting the cerebellum. Very little is known about the molecular mechanisms underlying the disease and, to date, no cure or treatment is available. We have successfully generated bona fide induced pluripotent stem cell (iPSC) lines of SCA2 patients in order to study a disease-specific phenotype. Here, we demonstrate the gene correction of the iPSC line H196 clone 7 where we have exchanged the expanded CAG repeat of the ATXN2 gene with the normal length found in healthy alleles. This gene corrected cell line will provide the ideal control to model SCA2 by iPSC technology.


Research Categories

Main Subject Area

Fields of Research

Links & Metrics

NORA University Profiles

University of Copenhagen

Danish Open Access Indicator

2016: Realized

Research area: Medicine

Danish Bibliometrics Indicator

2016: Level 1

Research area: Medicine

Dimensions Citation Indicators

Times Cited: 5

Field Citation Ratio (FCR): 0.83

Relative Citation ratio (RCR): 0.25

Open Access Info

Pure Gold